| CAPAX | HBLYX | CAPAX / HBLYX | |
| Total Expense Ratio | 0.90 | 0.67 | 134% |
| Annual Report Gross Expense Ratio | 1.12 | 0.67 | 167% |
| Fund Existence | 38 years | 20 years | - |
| Gain YTD | 5.365 | 4.802 | 112% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 1500 | 250000 | 1% |
| Min. Initial Investment IRA | 250 | N/A | - |
| Net Assets | 669M | 11.1B | 6% |
| Annual Yield % from dividends | 3.45 | 3.29 | 105% |
| Returns for 1 year | 11.20 | 5.70 | 197% |
| Returns for 3 years | 36.27 | 19.00 | 191% |
| Returns for 5 years | 28.46 | 7.11 | 401% |
| Returns for 10 years | 76.03 | 42.90 | 177% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SPFCX | 20.31 | 0.25 | +1.25% |
| PGIM Jennison Focused Growth C | |||
| WMLIX | 36.25 | 0.22 | +0.61% |
| Wilmington Large-Cap Strategy Instl | |||
| MSACX | 21.73 | 0.10 | +0.46% |
| Morgan Stanley Inst Passport ovrs eq I | |||
| RALOX | 11.74 | -0.05 | -0.42% |
| Lazard Real Assets Open | |||
| SHISX | 61.73 | -0.68 | -1.09% |
| BlackRock Health Sciences Opps Svc | |||